|
ABOUT COMPANY
Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious diseases in which protein growth factor signaling plays a critical role. The company is headquartered in Cambridge, Massachusetts.
|
EARNINGS
Gross Profit (TTM): -58659000
Market Capitalization: 914566000
Operating Margin (TTM): -6.63
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.507
Revenue (TTM): 18203000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.799
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -3.411
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -50847000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|